Abiopharma

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of agilon health, Inc. - AGL

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ventyx Biosciences, Inc. - VTYX

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alvotech - ALVO

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc. - SLNO

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bicycle Therapeutics plc - BCYC

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anavex Life Sciences Corp. - AVXL

Tivic Acquires Ready-to-Scale cGMP Manufacturing and Development Assets to Accelerate Commercialization of Entolimod; Tivic Growth Backed By $90M+ Financing Package

STAAR Surgical Sets the Record Straight Regarding its Robust Go-Shop Process

DUNN JEFFREY W 🟡 adjusted position in 20.0K shares (1 derivative) of SI-BONE, Inc. (SIBN) at $19.33 Transaction Date: Dec 08, 2025 | Filing ID: 000006

Alvotech (ALVO) Faces Investor Scrutiny Amid Manufacturing Deficiencies Severely Impacting Assurances of 2025 Revenues and Adjusted EBITDA, Stock Tumbles 33% -- Hagens Berman

NLS Pharmaceutics Ltd. (NLSPW) Files Form 6-K

GRI Bio Announces Pricing of $8,000,000 Million Public Offering

(10% Negative) Enliven Therapeutics, Inc. (IMRA) Announces Clinical Trial Timeline Adjustment

Volition Solves Liquid Biopsys "Needle in a Haystack" Problem; Achieves 180-fold (18,000%) Enrichment

Inotiv - Inotiv Partners with VUGENE to Advance AI-Driven Drug Discovery and Bioinformatics Capabilities